The QualityStocks Daily Monday, October 28th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (NHEL) +150.00%

StockMarketWatch (ISEE) +82.80%

NetworkNewsWire (CLWD) +42.86%

The QualityStocks Daily Stock List

Telkonet, Inc. (TKOI)

SmallCapVoice, RedChip, FeedBlitz, Alternative Energy, Stock News Now, CoolPennyStocks, BullRally, Stock Rich, and HotOTC reported previously on Telkonet, Inc. (TKOI), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Telkonet, Inc. provides unique intelligent automation platforms at the vanguard of the Internet of Things (IoT) space. The Company helps commercial audiences better manage operational costs via its EcoSmart intelligent automation platform. Vertical markets that benefit from EcoSmart products include hospitality, education, military, government, healthcare and multiple dwelling housing. Telkonet has its corporate headquarters in Waukesha, Wisconsin.

Telkonet’s EcoSmart intelligent automation platform is supported by a full-suite of IoT-connected devices. These devices provide in-depth energy usage information and analysis. This allows building operators to cut energy expenses. The Company has successfully deployed more than 600,000 devices across greater than 3,000 properties.

The foundation of Telkonet’s EcoSmart platform is on four distinct pillars. One pillar is the EcoSmart suite of IoT products - connected devices. A second is EcoCentral – the Company’s cloud-based EMS dashboard. The third pillar is EcoSmart Mobile – Telkonet’s smart device app. The fourth pillar is EcoCare - its service and support subscription. The Company’s platform integrates with a broad spectrum of products serving varied markets.

This past March, Telkonet announced that it, and reseller partner, Legend Energy Advisors, deployed Telkonet's innovative EcoSmart energy-management platform at Murray Hill Marquis in New York, New York, with EcoSmart Mobile application control. EcoSmart Mobile gives tenants easy control of their apartment's comfort. This is while providing the property major opportunities for energy savings.

EcoSmart takes advantage of occupancy-sensing thermostats, stand-alone sensors, plugs, light switches, and top third-party integrations and automation, to intelligently control energy utilization and create immersive user experiences.

Recently, Telkonet announced it has teamed with Volara, the first voice-based hotel guest engagement solution, which turns voice into a strong hospitality business tool. Together, they now offer a hospitality environment in which guests can use voice commands to control intelligent in-room devices and platforms to set scenes within their own hotel rooms. These scenes can incorporate one device or numerous different devices to create the exact environment that a hotel guest requests.

Hotel operators can configure ‘scenes’ and ‘commands’, which will enable guests to select their comfort level and environment. These settings will be customized to the EcoSmart Platform devices deployed and the capabilities provided within the hotel.

Telkonet, Inc. (TKOI), closed Monday's trading session at $0.088, up 2.6838%, on 22,700 volume with 5 trades. The average volume for the last 3 months is 81,403 and the stock's 52-week low/high is $0.0511/$0.165000006.

chart

SANUWAVE Health, Inc. (SNWV)

Marketbeat.com, RedChip, TopPennyStockMover, SmallCapVoice, PennyStocks24, OTC Stock Review, Penny Stock Rumble, Streetwise Reports, The Green Baron, Greenbackers, OTCJournal, FeedBlitz, AllPennyStocks, OTC Stock Review, Explicit Penny Picks, Free Investment Report, Free Penny Alerts, Gladiator Stocks, InsidersLab, KillerPennyStocks, and Ox of Wallstreet reported on SANUWAVE Health, Inc. (SNWV), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

SANUWAVE Health, Inc. is a shock wave technology business. Its initial focus is on the development and commercialization of patented non-invasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. SANUWAVE Health researches, designs, manufactures, markets and services its products internationally. SANUWAVE Health is headquartered in Suwanee, Georgia.

The Company applies its patented Pulsed Acoustic Cellular Expression (PACE®) technology in wound healing, orthopedic/spine, plastic/cosmetic, and cardiac conditions. Its portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses. This produces new vascularization and microcirculatory improvement. This helps in restoring the body's normal healing processes and leads to regeneration of tissue.

SANUWAVE’s lead product candidate for the global wound care market, dermaPACE®, is CE marked across Europe. It has Canada, Australia, and New Zealand device license approval for the treatment of skin and subcutaneous soft tissue. In the U.S., dermaPACE is now under the Food and Drug Administration's (FDA's) de novo petition review process for the treatment of diabetic foot ulcers. Diabetic foot ulcer treatment additionally has approval in South Korea.

SANUWAVE’s belief is that it has demonstrated that its technology is safe and effective in stimulating healing in chronic conditions of the foot (plantar fasciitis) and the elbow (lateral epicondylitis) via its U.S. Class III PMA approved OssaTron® device, and also stimulating bone and chronic tendonitis regeneration in the musculoskeletal environment through the use of its OssaTron, Evotron® and orthoPACE® devices in Europe, Asia, and Asia/Pacific. Moreover, there are license/partnership opportunities for the Company’s shock wave technology for non-medical uses. This includes energy, water, food, and industrial markets.

In December of 2016, SANUWAVE Health announced that it, in partnership with Ortho-Medico, a member of B&Co, Herzele, Belgium, is sponsoring ongoing clinical investigation on diabetic foot ulcers (DFU). The trial will be conducted by the VUB (Free University of Brussels) and UZ Brussel (University Hospital).

Previous work in 2015 at this hospital found that DFU patients, treated in-home with the dermaPACE system, responded positively to the treatment. The trial will take the home-care procedures, used in a limited basis, and extend them to a randomized, controlled trial of 100 subjects. The intention of the trial is to compare the effectiveness of in-home treatment of DFUs utilizing dermaPACE versus in-home treatment of DFUs using standard of care only. The trial will help to provide evidence that dermaPACE can be used outside the clinical setting and increase the potential for increased sales in Europe.

In February 2017, SANUWAVE Health announced that the U.S. Patent and Trademark Office (USPTO) issued SANUWAVE patent number 9,566,209 titled "Shock Wave Electrodes with Fluid Holes", which has an expiration date on June 21, 2033. The patent relates to a new construction of the spark gap electrodes employed to generate acoustic pressure shock waves in the Company’s devices that allows a longer useful life for the applicators.

Recently, SANUWAVE Health announced that it is entering into a Memorandum of Understanding (MOU) with eKare, Inc. This is to develop novel wound care analysis and management solutions. Linking SANUWAVE's dermaPACE® wound treatment device with eKare's inSight® 3D wound imaging and analytics system, the two companies will work to produce the industry's most complete wound management solution. eKare’s commitment is to the design and development of wound assessment solutions utilizing the most contemporary machine intelligence, computer-vision, as well as mobile technology.

SANUWAVE Health, Inc. (SNWV), closed Monday's trading session at $0.1425, up 9.6154%, on 632,796 volume with 54 trades. The average volume for the last 3 months is 319,765 and the stock's 52-week low/high is $0.100000001/$0.330000013.

chart

Boston Therapeutics, Inc. (BTHE)

MissionIR,  Tiny Gems, SmallCapVoice, PennyStocks24,   FeedBlitz, Wall Street Mover,  RedChip, TaglichBrothers,  Stock News Now, TopPennyStockMovers, and Information Solutions Group  reported  earlier  on Boston Therapeutics, Inc. (BTHE), and  today we are reporting on  the Company, here at the QualityStocks Daily Newsletter. 

Boston Therapeutics, Inc. is a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases. The Company’s product pipeline  centers  on developing and commercializing therapeutic molecules  that  address diabetes and inflammatory diseases. OTCQB-listed,  Boston Therapeutics is based in Lawrence, Massachusetts.

The Company’s  product pipeline includes BTI-320. This is a  non-systemic, non-toxic,  chewable complex carbohydrate-based compound. The design of it is to lessen post-meal glucose elevation. BTI-320 is a proprietary polysaccharide. 

BTI-320 works in the gastrointestinal tract to block the action of carbohydrate-hydrolyzing enzymes, which break down complex carbohydrates into simple sugars, reducing  the availability of glucose for absorption into the bloodstream. 

Boston Therapeutics  entered a  clinical trial agreement with Joslin Diabetes Center to be the lead clinic  in a Phase II study of BTI-320. In addition,  the Company’s  product pipeline  includes IPOXYN™. This is an injectable anti-necrosis drug. The design of it at first is to treat lower limb ischemia associated with diabetes.  

Boston Therapeutics’  product pipeline also  includes OXYFEX™. This product can serve as the only available oxygen delivery mechanism for animals suffering ischemia or traumatic and surgical blood loss events. OXYFEX™ is  the Company’s  veterinary facsimile to IPOXYN™.

Furthermore, Boston Therapeutics  developed and markets SUGARDOWN®. This is a non-systemic,  complex carbohydrate-based dietary food supplement. The design of SUGARDOWN® is to support healthy blood glucose.

SUGARDOWN®, in its present formulation, is a natural sugar blocker dietary supplement product made completely from a non-digestible sugar molecule, which can help people maintain healthier weight levels. It is the first chewable tablet of its kind. 

In 2015, Boston Therapeutics announced that its affiliate, Advance Pharmaceutical Company Limited (APC), began the  SUGARDOWN®  clinical trial in Hong Kong. Advance is evaluating the effect of  SUGARDOWN®  on Post-Prandial Hyperglycemia in Chinese subjects with Pre-Diabetes.  The lead clinical site is the Department of Medicine, The Chinese University of Hong Kong  (CUHK), Prince of Wales Hospital. 

In April 2017, Boston Therapeutics and  Advance Pharmaceutical announced the fully funded new trial plans to support the safety and efficacy of BTI-320, starting with a randomized, placebo-controlled, double-blinded, multi-center, global study on type 2 diabetic (T2D) patients.

Recently, Boston Therapeutics announced that effective sugar reduction with the investigative BTI-320 formulation necessitates only one tablet. Findings were confirmed by the most recent proof-of-concept study conducted in high-risk Chinese subjects with pre-diabetes. A formulation, in the form of a dietary supplement, is currently available as SUGARDOWN®, SUGARBLOCK and SUGARBALANCE in the Unites States and Asia.

Moreover, in December, Boston Therapeutics announced that it expanded its partnership with Advance Pharmaceutical Company Limited (APC) to distribute in Korea. Following the extension of the licensing and distribution agreement with APC, a registered formulation, marketed as a food supplement under the name SUGARBALANCE is now available in Korea. This significant shipment marks a start to the sales of SUGARBALANCE in the territory.

Boston Therapeutics, Inc. (BTHE), closed Monday's trading session at $0.0116, up 46.8354%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 51,959 and the stock's 52-week low/high is $0.007899999/$0.05.

chart

ProGreen US, Inc. (PGUS)

Amigo Bulls, InvestorsHub, Market Exclusive, Morningstar, Stockhouse, Marketwired, Uptick Newswire, Investors Hangout, Insider Financial, Penny Stock Prodigy, Promotion Stock Secrets, Barchart, MarketWatch, GuruFocus, and GlobeNewswire reported earlier on ProGreen US, Inc. (PGUS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

ProGreen US, Inc. engages chiefly with investments in agricultural and real estate projects in Baja California, Mexico. The Company is concentrating on intensifying its property investments in Baja California, Mexico, through its joint venture (JV) partnership with Inmobiliaria Contel, and via its subsidiary Procon Baja JV.  ProGreen US is based in San Diego, California.

Concerning ProGreen US’s Baja Project, the Company entered into a JV with a Mexican landowner, Inmobiliaria Contel and has jointly created Pro Baja. This is its newest JV with ProGreen owning 51 percent and Inmobiliaria Contel 49 percent. ProGreen US established an office location in Ensenada. This office serves as headquarters for all of its activities in Baja California. At present, Contel is active in the high margin produce industry, growing crops for exporters to the U.S. market, with an abundance of land available for expansion under its JV partnership.  

Moreover, 5,100 acres of land was acquired by Procon Baja JV, with 4.7 miles of oceanfront on the Bay of El Rosario, for which a master plan is being drawn for the development of a very large, completely green, global vacation and retirement community named "CieloMar." ProGreen US completed development of the first tract of land, which comprises roughly 300 acres. Of this, some 100 usable acres were cleared.

ProGreen US previously signed another agreement for a further 1,900 acres (500-800 usable for farming), and a 3-year option for 11,500 acres (1000-2500 usable for farming). The land, once developed and prepared, will be offered for long term lease (10-15 years), with the JV holding the title.

ProGreen US previously announced that it's subsidiary, Procon Baja JV (Procon), closed on the purchase and took possession of the new 2,500-acre tract of land in Baja California. The total purchase price is $160,000 (USD).

ProGreen Farms™ Rancho Arenoso is growing chili peppers on the approximately 100 acres now undergoing farming. It has plans for diversifying the operation with other types of produce for U.S. buyers as it expands onto the close by 2,500 acres that ProGreen's Mexican subsidiary, Procon Baja JV, acquired in June of 2018.

Recently, ProGreen US, in combination with its subsidiary, Procon Baja JV, executed a joint venture (JV) alliance contract with real estate giant EXIT Corp International's most successful regional franchise owners of EXIT Southeast. Exit Southeast (EXIT) will coordinate U.S. operations and initiate strategic sales/marketing of Cielo Mar Baja California Resort Sales.

This deal will target and deploy EXIT's 11,000-plus agents, with an extensive database of buyers/investors to commence presales corporate wide, throughout their connected 800 offices in the U.S. and Canada. The Exclusive Contract with EXIT Realty starts March 1, 2019. It gives EXIT access to Cielo Mar’s 10,000-plus unit inventory of Single Family Homes and Multi-Family Condos over the course of the 4 1/2 mile, 5000 acre oceanfront development.

ProGreen US, Inc. (PGUS), closed Monday's trading session at $0.0005, up 25.00%, on 6,551,321 volume with 10 trades. The average volume for the last 3 months is 1,643,845 and the stock's 52-week low/high is $0.000399999/$0.0034.

chart

Calmare Therapeutics, Inc. (CTTC)

OTCBB Journal, TaglichBrothers, and SmallCapVoice reported earlier on Calmare Therapeutics, Inc. (CTTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Calmare Therapeutics, Inc. (the Calmare Pain Mitigation Therapy™ company) researches, develops, and commercializes chronic, neuropathic pain, and wound affliction devices. Calmare devices sell commercially to medical practices internationally. In addition, they are found in U.S. military hospitals, clinics, and on installations through the Company’s General Services Administration (GSA) military contract (V797P-4300B). Calmare Therapeutics is headquartered in Fairfield, Connecticut.

Calmare’s medical devices provide a non-pharmacological (no drugs), non-addictive (no narcotics), and non-invasive (over the skin) solution to chronic pain sufferers in an outpatient treatment setting. The Company supplements its medical devices with a catalogue of private label neurostimulation and sensory electrodes.

The Company’s flagship medical device is the Calmare® Pain Therapy Device. This is the world's only non-invasive and non-addictive modality that can successfully treat chronic, neuropathic pain. Calmare Therapeutics holds a U.S. Food & Drug Administration (FDA) 510k clearance designation (K081255) on its flagship device. This grants it the exclusive right to sell, market, research, and develop the medical device in the United States.

Concerning CALMARE® Pain Therapy Treatment, the device is FDA-cleared for U.S. sales, U.S. patented, and patent pending in other countries, and medically certified in Europe. The Calmare® Pain Therapy Device treats oncologic and neuropathic pain through a biophysical rather than biochemical approach.

In January 2017, Calmare Therapeutics announced it was approved to list and supply four sensory and stimulation electrodes and the Calmare® Pain Therapy Device on the GSA Advantage!® web portal. GSA Advantage! is the online shopping and ordering system, which provides access to thousands of contractors and millions of supplies (products) and services.

Calmare Therapeutics has been a preferred vendor of the U.S. federal government (GSA#V797P-4300b) since 2010. Devices, consumables, as well as related hardware sell to U.S. military hospitals and clinics across the U.S. The Company sells its devices in Europe under CE-mark designation.

Calmare creates partnerships with its clients and customers to maximize their Intellectual Property (IP) assets, reduce time-to-market, and add to their profitability. The Company’s Technology Sourcing Service seeks technologies that fit with customer business goals and presents them as potential licensing or IP acquisition candidates.

Greater than 6,000 chronic pain patients have been successfully treated with Calmare Pain Mitigation Therapy™ since the initial Calmare chronic pain treatment was administered in 2007. Calmare Therapeutics has licensed more than 500 technologies to more than 400 individual organizations.

Calmare Therapeutics, Inc. (CTTC), closed Monday's trading session at $0.13, up 30.00%, on 13,479 volume with 4 trades. The average volume for the last 3 months is 8,250 and the stock's 52-week low/high is $0.011099999/$0.237399995.

chart

Blue Line Protection Group, Inc. (BLPG)

Penny Stock Tweets, Stockwolf, Marketwired, YCharts, Capital Cube, Awesome Penny Stocks, Barchart, New Cannabis Ventures, Marijuana Stocks, Cannabiznetwork, and Dividend Investor reported earlier on Blue Line Protection Group, Inc. (BLPG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Blue Line Protection Group, Inc. provides consulting, armed security, compliance and investigations, transportation, and secure vaulting services to banks, businesses and government entities. The Company’s professional team consists chiefly of former military and law enforcement personnel with decades of experience in protection, investigations, logistics, and tactical industries. Blue Line Protection Group is based in Denver, Colorado and lists on the OTC Markets.

The Company works side-by-side with retail establishments. It lessens the risk of criminal activity and creates a secure retail experience through protecting businesses on-site and securing their assets on the road.

Blue Line helps retailers remain compliant with all applicable laws. Furthermore, it shows retail establishments how to protect their businesses through letting Blue Line assume the responsibility and liability for their protective services.

The Company serves banks and credit unions through providing currency processing and transportation solutions. Its risk mitigation services help financial institutions serving cash-intensive industries comply with federal “know your customer” mandates. Blue Line Protection Group announced in October of 2018 that its Cash In Transit (CIT) operations, including vaulting, processing, and tactical compliance, is now available in Arizona.

Blue Line acts on behalf of banks and credit unions through collecting cash sales revenue from their client locations. Upon collecting the currency, the Company transports it to one of its secure processing facilities. Blue Line provides currency handling and validation services for the bank and transportation of processed currency to the Federal Reserve.

Blue Line Protection Group and Hypur have plans to open a cash vaulting and processing facility. This is to serve marijuana-related businesses (MRBs) and cash-intensive businesses (CIBs) in Nevada. Blue Line plans to partner with Hypur to expand services to Arizona, Oregon, Washington, California and Nevada. Hypur is a financial technology company based in Scottsdale, Arizona. The new Nevada facility will implement “Hypur Vault” cash management technologies.

Blue Line Protection Group’s Professional Affiliations include National Cannabis Industry Association, ASIS International, Marijuana Industry Group, Society of Corporate Compliance and Ethics, and Marijuana Business Association. Its Professional Affiliations also include International Association of Chiefs of Police, Professional Private Investigators Assn of Colorado, and Society for Human Resources Management.

Blue Line Protection Group, Inc. (BLPG), closed Monday's trading session at $0.0005, up 25.00%, on 1,121,100 volume with 10 trades. The average volume for the last 3 months is 7,839,215 and the stock's 52-week low/high is $0.000399999/$0.0043.

chart

Ethos Gold Corp. (ETHOF)

Stocks News Feed, Stockwatch, Penny Stock Hub, Mining and Energy, Marketwired, Resource Stock Digest, 4-Traders, The Street, Stockhouse, MarketWatch, InvestorsHub, YCharts, Streetwise Reports, GuruFocus, TradingView, Mining News North, YCharts, Dividend Investor, and Investors Hangout reported previously on Ethos Gold Corp. (ETHOF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Ethos Gold Corp. concentrates on the acquisition and exploration of mineral properties around the world. Currently, the Company holds one property in the White Gold District in the Yukon Territory. Ethos Gold has 100 percent ownership in the WC property. The Company primarily explores for gold, antimony, arsenic, lead, and silver deposits. Ethos Gold is headquartered in Vancouver, British Columbia. Incorporated in 2007, the Company lists on the OTC Markets Group’s OTCQB.

Ethos Gold’s WC property comprises 44 contiguous quartz claims totaling about 815 ha. The WC property is a target for intrusion-related 'Pogo-style' mineralization or fault controlled epithermal systems such as the nearby Coffee Deposit. Ethos Gold contracted Ground Truth Exploration, Inc. in 2012 to conduct a small 301 soil geochemical sampling program for the WC property. This was completed in July of 2012.

The intention of the program was to identify areas of interest based on anomalous gold in soil values and to establish the mineral potential of the property. Fourteen sample sites returned values in excess of 10 ppb Au with a maximum value of 171 ppb Au. The sample with the second highest gold concentration (119 ppb Au) has coincident anomalous antimony (19 ppm Sb), arsenic (117 ppm As), lead (200 ppm Pb), and silver (13 ppm Ag). The anomalous multi-element chemistry is similar to that identified by Ethos Gold at the Betty property, attributed to bonanza vein mineralization derived from and related to Western Copper's Casino Au-Cu-Mo porphyry.

Recently, Ethos Gold announced the completion of the 2018 sampling and trenching program (Phase 2 work) and to provide initial trench results for its Pine Pass vanadium project, situated on the John Hart Highway, northeastern British Columbia about 70 kilometers west of Chetwynd, and 200 kilometers north of Prince George.

Mr. Craig Roberts, P.Eng., President and Chief Executive Officer of Ethos Gold, stated, "We are very pleased and excited with these initial trench and chip sampling results. In Trenches 1 and 2 the grades are comparable with other development stage black shale hosted vanadium projects and the widths are impressive. These trenches are located 1.1 km apart and with the mineralization hosted in dipping bedded stratigraphy the drill target in this area appears relatively well defined with a significant target envelope.”

Ethos Gold Corp. (ETHOF), closed Monday's trading session at $0.136, up 20.354%, on 3,074 volume with 4 trades. The average volume for the last 3 months is 61,000 and the stock's 52-week low/high is $0.089900001/$0.249899998.

chart

Medibio Limited (MDBIF)

Awesome Penny Stocks, Wallet Investor, The Street, TradingView, Morningstar, Penny Stock Hub, Stockwatch, OTC Markets, Investing Online, Otc.Watch, Investors Hangout, Stockhouse, 4-Traders, and Global Banking and Finance reported earlier on Medibio Limited (MDBIF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Medibio Limited is a digital health company with offices in Melbourne (Vic), and Minneapolis, Minnesota. It has developed an objective testing system to assist in the screening, diagnosis, and treatment effectiveness of depression, chronic stress, and other mental health disorders. The test uses patented (and patent pending) circadian heart rate variability and cloud based proprietary algorithms to deliver a quantifiable measure to assist in clinical diagnosis. Medibio lists on the OTC Markets’ OTCQB.

Medibio is on course to commercialize its platform technology called the Digital Mental Health Platform. The basis of this is on patented biomarkers from the autonomic nervous system. The Company’s technology will provide a Diagnosis Aid to help General Practioners (GPs) and mental health clinicians. Medibio’s technology provides the first objective measure of stress. It provides a series of user and corporate dashboards for assessment and wellness partner interventions.

Regarding biomarker based objective diagnosis, a panel of circadian, sleep, and automatic system biomarkers enables automated, repeatable, and objective characterization of the impact of mental illness on the physiologic state. Medibio’s Digital Mental Health Platform is a device agnostic platform. It can ingest data from many devices. It is highly scalable, low cost, as well as easy to integrate.

Medibio announced in October 2018 the release of ilumen™. This is its product and platform for corporate customers. ilumen™ is a corporate wellness product providing employers the ability to offer biometric analysis and objective, data-driven feedback along with a mental wellness assessment to their employees.

This past November, Medibio announced that it signed an exclusive agreement with AIAA to undertake a pilot program for the latest release of its corporate health program, ilumen™. AIAA is one of Australia’s leading life insurers. AIAA is part of the AIA Group, which is the largest independent publicly listed pan-Asian life insurance group. It has a presence in 18 markets around the Asia-Pacific region. AIAA will have access to ilumen™ over a six-month period for its Australia and New Zealand employees.

Medibio Limited (MDBIF), closed Monday's trading session at $0.01, up 42.8571%, on 111,000 volume with 9 trades. The average volume for the last 3 months is 81,696 and the stock's 52-week low/high is $0.0013/$0.035.

chart

Destiny Media Technologies, Inc. (DSNY)

Wall Street Resources, Greenbackers, SmallCapVoice, Bullseyestox.com, Stockhouse, Blaque Capital Stocks, Breaking Bulls, and OTC Picks reported earlier on Destiny Media Technologies, Inc. (DSNY), and we report on the Company today, here at the QualityStocks Daily Newsletter. 

Destiny Media Technologies, Inc. provides services that enable content owners to securely display and distribute their audio and video content digitally via the internet. The Company’s two major services are Play MPE® and Clipstream®. It has granted patents for secure distribution and watermarking and a pending patent for cross platform PC and mobile streaming. Destiny Media Technologies is based in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

Play MPE® provides a standardized method to securely and cost effectively distribute pre-release music to radio stations and other music industry professionals, before it is ready for sale. Clipstream® is a video format that plays on any modern smart phone, tablet, internet, TV, or computer.

Destiny Media Technologies’ revenue and earnings growth has been propelled by the flagship Play MPE® system. The Play MPE® system is being embraced by the music industry as the standard for securely moving their pre-release music to radio stations and other recipients.

The Company has launched the next generation of the player used in the Clipstream® hosting and reporting service. This version contains the first approach in the industry utilizing the graphics processing unit of different devices to enhance the presentation of video within the browser using a browser technology named WebGL.

This new player can access resources unavailable to conventional technologies to upscale and enhance the video, improving the viewer experience. Initially designed for use in 3D rendering and game development, WebGL is a low-level 3D graphics API.  It gives the Clipstream player access to strong additional resources for enhancing and presenting video. In addition, the new player includes several other fixes and performance enhancements.

In late November, Destiny Media Technologies announced a change to its strategy. The Company said that effective immediately, Clipstream® business and technical development will be transitioned to maintenance and support only.

Presently, Destiny believes Clipstream® requires a considerable investment to continue to develop as a technology and as a business. As a result, the Company is reviewing strategic alternatives to capture the value of Clipstream®, its surrounding intellectual property (IP) and business, for its shareholders.

Destiny Media Technologies will focus its resources on worldwide expansion of Play MPE®. The Play MPE® business currently produces 99 percent of Company revenues.

For the fiscal 2017 year ended August 31, 2017, Destiny Media Technologies’ revenue increased in all geographic territories for a total increase of roughly 3 percent to $3,445,014. This, combined with an 11 percent decrease in overall expenditures (to $3,170,580), resulted in eliminating the prior year’s net loss increasing to net income of $288,781.

Destiny Media Technologies, Inc. (DSNY), closed Monday's trading session at $0.9744, up 8.2667%, on 9,892 volume with 45 trades. The average volume for the last 3 months is 23,480 and the stock's 52-week low/high is $0.070799998/$1.07000005.

chart

Stealth Technologies, Inc. (STTH)

NetworkNewsWire and RedChip reported previously on Stealth Technologies, Inc. (STTH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Stealth Technologies, Inc. is a technology business listed on the OTC Markets Group’s OTCQB. The Company previously went by the name Excelsis Investments, Inc. It changed its name to Stealth Technologies, Inc. in July 2016. Stealth Technologies engages in identifying and capitalizing on technology and associated markets. The Company produces products for personal and financial protection.

Incorporated in 2010, Stealth Technologies has its corporate office in Largo, Florida. It became public through a reverse merger in 2012.

Moreover, Stealth Technologies announced in March of this year the completion of five new products. Currently, these products are staged in a large direct response retailer's quality assurance and legal department. They are under final review to ensure that marketing claims associated with each product are accurate when measured against actual performance levels of each product, and that assurance and inventory is satisfactory and has met all quality control factors. Stealth Technologies’ strategic initiative is to expand its product footprint across varied industries and distributors.

The Company has developed a group of products to protect against "electronic pickpockets," emergency response latency, credit fraud protection, and cell phone data protection. Its initial product to market is the Stealth Card.

The design of the Stealth Card is to protect the Radio-Frequency Identification (RFID) chip in a consumer's credit card from electronic stealing or pickpocketing, which uses a smartphone, credit card reader, or RFID antenna to remotely access data stored on the consumer's Smartchip. Stealth Card renders the chipped information invisible to intrusion.

The Stealth Card is a 100 percent USA product. The Stealth Card is manufactured from Stealth Technologies’ laboratory and research/development facility in West Virginia to its manufacturing facility in Massachusetts.

Development for the Stealth Card started in 2012. This is when Company Founder and Chief Executive Officer (CEO), President, and Director, Mr. Brian McFadden, observed the worldwide shift towards smart chip card technology to transmit and process credit card/debit card transactions. With Europe and Asia already making the transition away from the magnetic strip to smart chip cards, Mr. McFadden believed the United States market would need to follow suit.

To use the Stealth Card, a person places a Stealth Card in their wallet, pocket, change purse or anywhere they carry their credit cards. One card can protect up to 12 cards in a wallet. The card can be physically placed anywhere in a wallet or pocket.

The card does not need to be in the front or back of one’s wallet. The Stealth Card provides effective protection irrespective of where it’s placed in relation to one’s credit cards. 

In December 2016, Stealth Technologies announced the development of the 911 Help Now Generation II Product. The 911 Help Now product provides a direct two-way voice connection to emergency service providers. The 911 Help Now pendent works by pressing the Help Now button and then a person is connected.

Stealth Technologies has a number of other products under development. The Company is exploring potential military applications of its proprietary technologies.

Along with the Stealth Card and the 911 Help Now Generation II Product, Stealth Technologies’ portfolio includes Data Secure Plus, which is new to market. Its portfolio also includes Stealth Mobile.

Stealth Technologies, Inc. (STTH), closed Monday's trading session at $0.0031, up 14.8148%, on 835,157 volume with 25 trades. The average volume for the last 3 months is 3,916,697 and the stock's 52-week low/high is $0.001599999/$0.028999999.

chart

Natcore Technology, Inc. (NTCXF)

Stockhouse, InvestorsHub, MarketWatch, OTC Markets, Business Insider, and StreetInsider reported on Natcore Technology, Inc. (NTCXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Natcore Technology, Inc. concentrates on using its proprietary Foil Cell technology to considerably lower the costs and improve the power output of solar cells. The Company is creating the next generation of solar cells. Natcore is developing two main technologies. These are low-cost, all-back-contact solar cell structures, and Black Silicon cells.

A solar R&D company, Natcore Technology is headquartered in Rochester, New York. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s Foil Cell (All Back Contact Solar Cell) uses a high-speed, low temperature laser process. Natcore’s Black Silicon technology streamlines the path to low solar cell reflectance.

Natcore Technology has its Natcore Laboratory in Rochester. This is a 19,000 sq. ft. facility. It has 8,000 sq. ft. of ‘class 10,000’ clean room. The Company engages in the full solar cell process at this laboratory - from bare silicon wafer to working cells.

Regarding the Company’s Foil Cell Structure, the process involves multilayer foil metallization. Key features/properties include low cost contact metals and simplified manufacture. This includes low capital equipment cost, small factory footprint, and low temperature processing.

Natcore Technology has established exclusive licenses and/or joint research agreements with Rice University, the National Renewable Energy Laboratory (NREL), Fraunhofer ISE and the University of Virginia. The Company has received 33 patents; 32 patents are pending.

Recently, Natcore Technology announced it significantly streamlined the fabrication method for its pioneering Natcore Foil Cell™. This allows for even lower-cost production methods.

The Company is targeting greater than 25 percent real-world efficiency for its eventual production solar cells. This is approximately a 25 percent performance improvement over numerous high-end commercial cells being installed today.

The use of laser processing to create the Company’s unique, all-back-contact cell structure has been eliminated and replaced by a carrier selective contact process. This is combined with a foil metallization, which can be inexpensively made with high-speed roll-processing methods. Natcore has started an accelerated development program to produce a prototype with the new process, and also include production cost and efficiency modeling by independent authorities.

Natcore Technology, Inc. (NTCXF), closed Monday's trading session at $0.02, up 33.3333%, on 20,000 volume with 2 trades. The average volume for the last 3 months is 13,926 and the stock's 52-week low/high is $0.001099999/$0.115000002.

chart

Broadway Gold Mining Ltd. (BDWYF)

Streetwise Reports, Stockhouse, Barchart, and InvestorsHub reported on Broadway Gold Mining Ltd. (BDWYF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

A resource company, Broadway Gold Mining Ltd. centers on development-stage projects with advanced exploration potential. The Company owns a 100 percent interest in the Madison copper-gold project in the Butte-Anaconda mining region of Montana. Broadway Gold Mining’s shares trade on the OTC Markets Group’s OTCQB. The Company has its corporate office in Vancouver, British Columbia.

The Madison copper-gold project is permitted for exploration. It contains a past-producing underground mine that Broadway Gold Mining has refurbished. The Company is expanding known copper and gold zones, which remain open for development in the mine's perimeter.

Broadway’s exploration program has identified new anomalies across its wide-ranging land package. These provide drill targets believed to be associated with large-scale porphyry mineralization.

The Company identified copper-gold porphyry targets at Madison in 2017, supported by a newly assembled geological model. Phase I and II drilling this year returned high-grade gold and copper intersections from shallower skarn zones. Many high-priority targets, including porphyry, will be the emphasis of Phase III drilling.

In October, Broadway Gold Mining announced the discovery of a new latite porphyry zone of mineralization at its Madison project in the legendary Butte-Anaconda mining region of Montana.

Mr. Duane Parnham, Broadway Gold Mining’s President and Chief Executive Officer, said, "Broadway's technical team has successfully delivered on a fourth major milestone worthy of additional testing by discovering a porphyry system underlying the shallower skarn zones, which were mined in the past and expanded in our recent drilling. Although indications suggest a typical copper porphyry alteration system is present, this new mineralization discovered at Madison exhibits similar characteristics to the latite porphyry hosted at Barrick's Golden Sunlight Mine (GSM) located 36 kilometers away in Whitehall, Montana."

Recently, Broadway Gold Mining announced that, as a result of its recent porphyry discovery, it has staked additional ground to cover favorable geological and geophysical targets in the area of its 100 percent-owned Madison copper-gold project.

The new claims are contiguous to the south of the Company’s active exploration area. The new claims extend the current Madison property footprint to 2,514 acres.

Broadway’s Phase III drilling program continues. The Company is fully funded for completion of the program. Deeper geophysical targets from the 2017 survey appear to trend through the original property boundary onto the newly acquired claims.

Broadway Gold Mining Ltd. (BDWYF), closed Monday's trading session at $0.0662, up 26.3359%, on 610 volume with 1 trade. The stock's 52-week low/high is $0.009999999/$0.129999995.

chart

China YCT International Group, Inc. (CYIG)

SquawkBoxStocks, Penny Pick Finders, TerrificPennyStocks, Breaking Bulls, AwesomeStocks, PennyStocks24, Chatter Box Stocks, MyBestStockAlerts, Buzz Stocks, PennyStockCrowd, Marquee Penny Stocks, Penny Stock Rumble, PennyStocksV2, and Planet Pennies reported earlier on China YCT International Group, Inc. (CYIG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

China YCT International Group, Inc is a developer, manufacturer, and distributor of traditional Chinese medicines (TCM). A biotechnology company, it mainly concentrates on producing medicines and selling organic healthcare products. In addition, China YCT is a significant player in the Acer Truncatum oil business. The Company anticipates that this will be a billion-dollar market in the near future.

China YCT International Group has its head office in Sishui County, Shandong Province, China. It lists on the OTC Markets Group’s OTCQB.

The Company engages in developing, manufacturing, and selling its own TCM’s made primarily from ginseng extract, manufacturing and distributing acertruncatumbunge seed oils, and distributing health care supplement products in China.

China YCT International Group announced in May 2017 that it signed an agreement to purchase the Acer Truncatum business from Shandong YCT Group Co. Ltd. The expectation is that this new business will increase sales by a billion U.S. dollars for China YCT in the next 5 years.

Acer Truncatum is a kind of maple. It has 300 species around the world. Acer Truncatum is only available in China.

The Acer Truncatum oil contains 5.8 percent of nervonic acid. Acer Truncatum is contained in plants, and nervonic acid can undergo extraction from these very economically. After more than 40 years’ research and experiments, the Chinese government approved Acer Truncatum oil as general wood food oil that can be used as a general food oil, such as soybean, corn, olive, as well as other food oils.

Recently, China YCT International Group announced its financial results for the fiscal year ending March 31, 2017. The Company achieved $56,463,164 in revenue. This represents an increase of 18.1 percent or $8,636,056, versus $47,827,108 for the same period the year prior.

The Company achieved net income of $10,054,654. This represents a 19.5 percent or $1,637,885 increase, versus $8,416,769 during the fiscal year ended March 31, 2016.

Mr. Yan Tinghe, China YCT International Group's Chief Executive Officer, said, "The Company's next business goal is to become a leading enterprise in research, cultivation, and production in the domestic and international market for acertruncatum woody edible oils."

China YCT International Group, Inc. (CYIG), closed Monday's trading session at $0.135, up 60.7143%, on 3,000 volume with 2 trades. The average volume for the last 3 months is 6,067 and the stock's 52-week low/high is $0.079999998/$1.05999994.

chart

Natural Health Farm Holdings, Inc. (NHEL)

Stockopedia, Stockhouse, Market Exclusive, Capital Cube, 4-Traders, Street Insider, Morningstar, Simply Wall St, InvestorsHub, OTC Markets, GuruFocus, MarketWatch, Last10k, and Barchart reported earlier on Natural Health Farm Holdings, Inc. (NHEL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Natural Health Farm Holdings, Inc. is a biotechnology company working to establish a complete healthcare one-stop shop based on natural or naturopathic products. Since November of 2017, the Company has developed and started to commercialize the web-based Naturopathic Learning Management System to enable consumers and distributors to be educated on health-related aspects of various diseases and nutritional consulting services. Natural Health Farm Holdings is headquartered in Las Vegas, Nevada. The Company lists on the OTCQB.

Natural Health Farm provides online nutritional consultation services. It does so through offering a web-based naturopathic learning management system. This system educates their customers on general wellbeing. The Company’s principal activities are in retailing nutritional supplements, organic foods and health-care related products.

Via its subsidiary, NHF International Limited, Natural Health Farm specializes in biotechnology research & development, and a retail business. It has a chain of numerous retail & franchise outlets throughout Malaysia and other nations. These include Singapore, Brunei, Philippines, China, Hong Kong and the United States.

Natural Health Farm Holdings announced this past January that it executed a term sheet to acquire all of the issued and outstanding shares of Natural Tech R&D Sdn Bhd, a BioNexus accredited research and development company in Malaysia. With the agreement, Natural Health Farm shall acquire 100 percent of Natural Tech R&D’s outstanding shares for USD 1 Million.

Natural Health Farm Holdings also announced in January that it executed a term sheet to acquire all of the issued and outstanding shares of Excel Herbal Industries Sdn Bhd. Excel Herbal is a nutraceutical biotechnology manufacturing, organic food and health supplements business in Malaysia.

Recently, Natural Health Farm Holdings announced that it executed a term sheet to acquire all of the issued and outstanding shares of Natural Health Naturopathic Academy Sdn Bhd (NHNA), a Malaysian healthcare education provider. Natural Health Naturopathic Academy offers courses on health, nutrition, dietetic and Chinese & natural medicine, which are accredited by over 30 countries.

Natural Health Farm Holdings also recently announced that it executed a term sheet to acquire a majority equity interest in Biodelta (Pty) Ltd. Biodelta is a contract developer and manufacturer of nutraceutical products in South Africa. Furthermore, this month, the Company announced that it executed an agreement to acquire all the issued and outstanding shares of Natural Health Farm, Inc. (NHF). NHF is a distributor of naturopathic and nutraceutical products in North Carolina and throughout the East Coast of the United States.

Natural Health Farm Holdings, Inc. (NHEL), closed Monday's trading session at $0.025, up 150.00%, on 60,100 volume with 4 trades. The average volume for the last 3 months is 976 and the stock's 52-week low/high is $0.000099999/$6.00.

chart

The QualityStocks Company Corner

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (ETST) was featured today in a publication from HempWireNews, examining how the future of hemp in Georgia begins at University Georgia where there are several dozens of plants ready for harvesting. The crops, planted on a one-third acre, are now sprouting fuzzy flowers, which are used to make the CBD oil used for treating conditions such as anxiety and insomnia.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed Monday's trading session at $0.37, up 5.7143%, on 6,117 volume with 10 trades. The average volume for the last 3 months is 42,042 and the stock's 52-week low/high is $0.280000001/$1.07000005.

Recent News

chart

MustGrow Biologics Corp. (CSE: MGRO)

The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..

In cannabis, MustGrow Biologics Corp. (CSE: MGRO) is currently developing reliable, safe and biological solutions that adhere to Health Canada’s strict regulations.  Furthermore, the company currently has three products suited for the cannabis market: a mustard-derived bio-pesticide, CannaProtector®, to treat soil borne pests and diseases; a bio-fungicide, CannaVate®, that can be used a foliar application for powdery mildew; and a bio-fertility product, TP-1000, to increase yield, THC and terpene levels.  Additionally, CannaVate® and TP-1000 are in-licenced products for which MustGrow has exclusive rights in Canada.  Also, CannaProtector® is based on MustGrow’s patented natural biologic technology made from mustard seed that acts as a bio-pesticide.

MustGrow Biologics (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.

Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://nnw.fm/Qkz21). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical?formulations.

MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.

MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.

Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:

  • 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
  • 55 percent tomato crop yield increase
  • 95 percent control of Pythium root rot in lettuce fields
  • 70 percent reduction in Verticillium root severity in cucumbers
  • Market Opportunity

Market Opportunity??

MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?

Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??

MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.

Management Team

President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.

Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.

COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.

Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.

Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.

CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.

MustGrow Biologics Corp. (CSE: MGRO), closed Monday's trading session at $0.295, up 3.51%, on 48,350 volume with 60 trades. The average volume for the last 3 months is 26,604 and the stock's 52-week low/high is $0.25/$0.699999988.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America (OTCQB: MCOA) , an innovative hemp and cannabis corporation, is pleased to announce that the Company's wholly owned subsidiary, hempSMART™, Inc., has entered into a CBD beverage product supply agreement with MCTC Holdings, Inc. (OTC: MCTCD) (OTC: MCTC).

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed Monday's trading session at $0.2098, up 9.2708%, on 256,542 volume with 144 trades. The average volume for the last 3 months is 303,468 and the stock's 52-week low/high is $0.023/$2.10599994.

Recent News

chart

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)today announced final results from the recently-completed detailed recovery process bench scale test program. According to the update, extractive technology and mineral process development partner Process Research ORTECH Inc. (“PRO”) is conducting the test program for the selection of a suitable process for recovery of nickel and cobalt from laterite material. To view the full press release, visit http://nnw.fm/htB4E.

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed Monday's trading session at $0.1355, up 12.9167%, on 17,741 volume with 10 trades. The average volume for the last 3 months is 30,816 and the stock's 52-week low/high is $0.070100001/$0.259299993.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands, LP (VPRB) was featured today in a publication from HempWireNews, examining how, in the U.S, there are 35 states growing hemp for commercial purposes, and Georgia is looking to be a significant contributor to the industry. According to Hemp Industry Daily, this year, the CBD sales are estimated to be $1.2 billion globally, and an increase of $6 billion is forecasted by 2022.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed Monday's trading session at $0.045, even for the day, on 12,943 volume with 6 trades. The average volume for the last 3 months is 134,471 and the stock's 52-week low/high is $0.033799998/$0.119999997.

Recent News

chart

B2Digital Inc. (OTC: BTDG)

The QualityStocks Daily Newsletter would like to spotlight B2Digital Inc. (BTDG).

B2Digital Inc. (OTC: BTDG) was featured today in a publication from NetworkNewsWire, examining how the growth in popularity of mixed martial arts (MMA) during the past decade to a lofty position where it ranks just behind soccer and basketball as the world’s third most popular sport has opened a potential bonanza for the people who can properly organize and promote a good fight.

B2Digital Inc. (OTC: BTDG) is applying its extensive background in entertainment, television, video and technology to become a full-service live event sports company. Capitalizing on its strong management team, industry relationship, and hands-on experience in the industry, B2Digital is developing and acquiring Mixed Martial Arts (MMA) and sports-related companies to build an integrated premier development league initially for the billion-dollar MMA marketplace.

B2Digital’s management team boasts over 30 years of combined global experience developing more than 20 companies within the sports, television, entertainment, digital distribution and banking transaction industries.

Since its restructuring in 2017, the company is now forging ahead with company chairman and CEO Greg P. Bell at the helm. His expertise, relationships and experience bring a background of more than 40,000 successful live events throughout his career. Under his guidance, B2Digital will create and develop the “Development League” champions that will move on to the MMA major leagues from within the B2 Fighting Series.

In preparation, B2Digital has produced and applied the systems and technologies required to support and maintain infrastructural operations of the company, including: social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial control systems. The company has also launched its B2 Social Media Network as the digital distribution system for the B2 Fighting Series.

As part of its growth strategy, B2Digital intends to continue to develop and acquire assets that meet its business model with the goal of becoming a premier vertically integrated live event sports company. In 2017, B2Digital started operating B2 Fighting Series, live MMA events; each year, the top fighters are invited to the live annual B2 Fighting Series National Championship.

Assets

B2Digital owns all rights for TV, internet, social media, media, merchandising and trademarks and branding for the B2Digital companies. The company has deployed its B2 Social Media Network digital distribution network for the B2 Fighting Series and has developed and deployed the systems and technologies for the operation of social media marketing, event engagement, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial control systems.

Fight Groups (holdings)

  • HRMMA
  • Colosseum Combat
  • United Combat League
  • Pinnacle Combat
  • Bluegrass MMA

B2 Social Media Network (B2SN)

The B2 Social Media Network (B2SN) provides the connection between the B2Digital live events and the consumer audience by:

  • Providing social interaction between consumers regarding B2Digital Properties and current relevant topics to the live events audience
  • Offering “FTV” free-to-view live and on-demand TV style broadcasts globally of B2 Digital live events
  • Promoting upcoming live events
  • Selling tickets to B2 live events electronically
  • Promoting the fighters, athletes and participants in the B2Digital live events

Download Report

Leadership

Chairman and CEO Greg P. Bell
Greg P. Bell is one of the early pioneers and entrepreneurs in entertainment and digital media and has been working in the field for over 30 years. He was involved in the early creation of the technologies and algorithms that allowed analog media to be transformed into digital bits and compressed data streams and created specific business enterprises that capitalized on the creation of digital transmissions at Scientific Atlanta, Compressions Labs, VCON International and Qwest. Bell was one of the initial vice presidents of business development at Qwest Communications where he developed Qwest’s digital media company, Slingshot Networks. He then ran all operations of Slingshot, reporting to the board of directors, which managed and operated three full time studios including the creation of the broadcast studio in Staples Center, TV and news productions, live events at the Staples Center, distribution of a national television show distributed by Warner Brothers TV Distribution, online television productions and web distribution for the NFL, AFL, NBA, NHL, Boxing, Democratic Convention and live music events.

Upon leaving Slingshot in 2000, Bell founded B3 Development Group, a firm specializing in developing emerging market entertainment and media companies. Bell’s B3 Development Group founded B2 Networks in 2001 which quickly became the defacto standard for watching live PPV sporting events online. B2’s proprietary online system broadcasts live professional and collegiate sporting events online to a global audience, broadcasting over 1,000 live games per month. Bell developed and implemented a merger with B2 Networks and the America ONE Television Network where he became CEO of the combined companies. Under Bell’s direction the company, now called ONE Media Corp., launched the new ONE World Sports TV Network in North America on cable and satellite, with a pure digital end-to-end distribution system, along with continuing the company’s growth in the online distribution of sports and entertainment.

After leaving as CEO of ONE Media Corp., he currently sits as chairman of B3 Development Group, which specializes in developing and fast-tracking emerging entertainment, transaction technology and media distribution companies. Bell continues to expand his holdings and currently has business holdings in ONE Media Corp; B3 Development Gaming Group which under contract with Caymanas Park Race Track, owned by the country of Jamaica, developed Jamaica’s first all-digital state of the art pari-mutuel live sports gaming system for mobile devices and currently is operating under the brand CaymanasToGO for the Caribbean Consumers and is licensed for deployment in the USA to USA-based consumers. The B3 Gaming Group mobile device wagering system and technology allows consumers globally to watch and wager on live horse races and sporting events being held in the UK, USA, Canada and the Caribbean; B3 Gaming Services Group, a premier transaction and customer service group that offers management services to the Gaming industry in the Caribbean, B3 Networks, a premier state of the art digital broadcasting company that developed the B3 television satellite replacement technology which allows TV networks to broadcast globally on the public internet instead of satellites in broadcast quality HD & SD television. B3 Networks has deployed, and services, the B3 technology to broadcast high definition TV signals globally to cable head ends, smart phones and internet connected devices for the Jamaica Education Television Network, the Caymanas Race Track and other mobile applications globally.

Bell has worked at the top technology development companies that developed the digital technologies, which are in use today at Scientific Atlanta, Compression Labs, VCON and Qwest. He also has managed and been directly involved with over 55,000 live events in his 30-year career. He has worked with a diverse group of clients in the entertainment, sports and technology communities including the NFL, NBA, NHL, AHL, NLL, ECHL, IFL, USHL, SPHL, NCAA, NAIA, MISL, AFL, AOL, FOX, UFC, NAAFS, Bellator, WEF, the Staples Center, the Orleans Arena, Oscar De La Hoya, Barbra Streisand, and top entertainment venues, acts and actors. His clients and companies have capitalized on Bell’s knowledge of the world of entertainment, live events, sports, digital television and digital online transaction and distribution systems.

B2Digital Inc. (BTDG), closed Monday's trading session at $0.0057, even for the day, on 16,500 volume. The average volume for the last 3 months is 307,909 and the stock's 52-week low/high is $0.0023/$0.039999999.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis-branded product company with the two best-selling cannabis products in California, is committed to careful, deliberate product research, formulation and delivery. As part of the company’s strategic plan to strengthen its reputable brand, PLUS has named its first-ever chief scientific officer, Dr. Ari Mackler (http://cnw.fm/JCdj7).

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Monday's trading session at $1.83, up 1.105%, on 60,106 volume with 113 trades. The average volume for the last 3 months is 38,195 and the stock's 52-week low/high is $1.80999994/$6.00810003.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX Inc. (NASDAQ: SRAX) provides the tools to unlock the value of data across marketing channels. A digital-marketing and data-management technology company, SRAX is building the largest and most valuable opted-in data set in the world with an emphasis on privacy and data ownership. Headquartered in Los Angeles, California, SRAX offers consumers the ability to market their own data while getting paid for the release of that data.

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Monday's trading session at $1.76, off by 8.3333%, on 487,929 volume with 1,567 trades. The average volume for the last 3 months is 89,114 and the stock's 52-week low/high is $1.54999995/$5.8499999.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) was featured today in a publication from CBDWire, examining how the fact that cannabidiol passed WHO abuse potential tests and was found to have no negative attributes is a godsend to those in need. They’ll be able to use the CBD products to manage their ailments and get a better quality of life without worrying about getting addicted to their medication.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Monday's trading session at $0.665, off by 5.00%, on 96,248 volume with 72 trades. The average volume for the last 3 months is 85,848 and the stock's 52-week low/high is $0.399800002/$1.70000004.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was featured today in the 420 with CNW by CannabisNewsWire. The lawmakers in Connecticut have allowed more medical marijuana qualifying conditions. On Tuesday, the General Assembly Regulations Review Committee added five qualifying conditions for adults. Two of the five conditions are intractable neuropathic pain and Tourette syndrome. Patients under the age of 18 with the two ailments were are also approved to use medical marijuana.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Monday's trading session at $0.591, off by 6.1905%, on 537,799 volume with 350 trades. The average volume for the last 3 months is 494,557 and the stock's 52-week low/high is $0.588800013/$1.7888.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently announced that its Skyline Medical Division completed the sale of 10 STREAMWAY(R) Systems to a major New York hospital (http://nnw.fm/B7hxg). To view the full article, visit http://nnw.fm/kBgf3.

Predictive Oncology (POAI) is a data and artificial intelligence-driven discovery services company that provides predictive models of tumor drug response to improve patient outcome. Predictive Oncology harnesses the power of artificial intelligence, collaborating with the pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for patients, which can lead to much more effective treatments.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable development of patient specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Predictive Oncology (POAI), closed Monday's trading session at $0.402, off by 10.6667%, on 81,244 volume with 162 trades. The average volume for the last 3 months is 61,712 and the stock's 52-week low/high is $0.351799994/$0.850000023.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

A diversified holding company, Sharing Services Global Corporation (OTCQB: SHRG)owns, operates or controls an interest in an array of companies specializing in the direct-selling industry. The company recently announced record Q1 revenues, with numbers totaling $35.4 million for its fiscal first quarter ended July 31, 2019 — more than double the revenue numbers of $12.9 million posted in the comparable quarter of 2018 (http://nnw.fm/zMbX9). In addition, the company reported cumulative sales of more than $129 million since its milestone launch of products in December 2017.

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed Monday's trading session at $0.14, off by 1.4085%, on 88,268 volume with 11 trades. The average volume for the last 3 months is 33,256 and the stock's 52-week low/high is $0.090000003/$0.3944.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) was featured today in a publication from CBDWire, examining how “Will I get addicted to CBD?” Is a legitimate question. especially considering the immense demand the products have garnered, coupled with how easily accessible it is. It is only last year that the Farm Bill legalized cultivating industrial hemp, the plant that produces cannabidiol (CBD). Given cannabidiol’s relation to its infamous psychoactive cousin, THC (tetrahydrocannabinol), a cannabinoid wrapped in controversy, it would be natural to pose such a question. Well, the World Health Organization (WHO) answered this question in a report which examined a ton of things about CBD, including the wonder drug’s potential for abuse. The report said that a “single-dose administration of cannabidiol had been valued healthy in volunteers using a variety of tests of abuse potential as well as physiological effects in a randomized, double-blind placebo-controlled test.”

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Monday's trading session at $0.0114, off by 4.2017%, on 2,905,872 volume with 113 trades. The average volume for the last 3 months is 2,670,225 and the stock's 52-week low/high is $0.009999999/$0.028999999.

Recent News

chart

LiveWire Ergogenics Inc. (OTC: LVVV)

The QualityStocks Daily Newsletter would like to spotlight LiveWire Ergogenics Inc. (LVVV).

The caliber of LiveWire Ergogenics Inc.’s (OTC: LVVV) research team members investigating the effectiveness of cannabinol (CBD)-based treatments of conditions particular to the equestrian is not only based on the decade-long outstanding track record of the individuals involved, such as Gunther Seidel, who won medals in team dressage at three different Summer Olympics and competed and placed in two World Championships, as well as in seven World Cup Finals, but was also recently demonstrated with two reserve champion rankings by Rebecca Rigdon-Blake during August’s U.S. Dressage Festival of Champions in Chicago.

LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.

During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:

PODs and Distribution in Coachella, California

For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.

Estrella Ranch in Paso Robles, California

Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.

 

The Paso Robles Nursery

LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.

LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.

GHC Ventures Subsidiary

GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.

GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.

Research Partnerships

LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.

LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.

7X Pure™ Dosing and Verification System

LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.

The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.

The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.

Acquisitions & Operations

To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.

Market Opportunity

Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.

The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.

Business Model

LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.

Management Team

LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.

Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.

As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.

Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.

Advisory Board

Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.

Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.

Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.

Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight?majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17?Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.

LiveWire Ergogenics Inc. (OTC: LVVV), closed Monday's trading session at $0.0061, off by 11.5942%, on 3,403,270 volume with 47 trades. The average volume for the last 3 months is 843,746 and the stock's 52-week low/high is $0.004199999/$0.07.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.